Chen Schor
About Chen Schor
Chen Schor is the President and CEO with over 25 years of experience in global biopharmaceutical leadership, known for leading strategic transactions worth over $8 billion and significant roles in company turnarounds and mergers.
Chen Schor - President and CEO
Chen Schor currently holds the position of President and Chief Executive Officer. He has accumulated over 25 years of leadership experience in the global biopharmaceutical industry, demonstrating his extensive expertise and management skills at the helm of various companies.
Chen Schor's Education and Expertise
Chen Schor has a well-rounded educational background, holding an MBA along with a B.A. in Biology and a B.A. in Economics. In addition to these degrees, he is also a Certified Public Accountant. His educational achievements provide a solid foundation for his versatile career in business and biopharmaceuticals.
Chen Schor's Industry Leadership
With more than 25 years in the biopharmaceutical sector, Chen Schor has led and executed strategic transactions that amount to over $8 billion with major companies such as GSK, Amgen, Pfizer, and Merck KGaA. His ability to navigate and lead in this highly competitive field reflects his industry acumen.
Chen Schor's Significant Business Roles
Chen Schor has held significant roles throughout his career, including Vice President of Global Branded Business Development and Pipeline Management at Teva Pharmaceuticals and being a Partner at Yozma Venture Capital. At Yozma, he contributed to the foundation and growth of multiple therapeutic companies.
Chen Schor's Board Memberships
Chen Schor is an active member of the board with several organizations. He is a board member of the Alliance for Cancer Gene Therapy, Karyopharm Therapeutics, and serves as Chairman of the Board for Carbon Biosciences. His involvement with these boards underlines his commitment to advancing biopharmaceutical and therapeutic innovations.